Literature DB >> 33039370

Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.

Saba Yasir1, Zongming Eric Chen1, Samar Said1, Tsung-Teh Wu1, Michael Torbenson2.   

Abstract

The reticulin stain is a critical diagnostic aide used to differentiate benign hepatocellular proliferations from well differentiated hepatocellular carcinoma (HCC). Rarely, however, hepatocellular carcinomas do not show definitive loss of reticulin in liver biopsy specimens. To study this group of tumors, 11 HCC with no reticulin loss in 10 patients were collected and studied. Analysis of demographics showed a typical enrichment for men with a typical age for HCC presentation of 69 ± 7 years for adults. The background livers showed advanced fibrosis or cirrhosis in 6 of 6 cases with available information. The tumors were all well differentiated. Cytological atypia was mild and consisted of very mild nuclear atypia (8 cases), mild increase in N:C ratio (3 cases), and pseudorosette formation (4 cases). The cytological/architectural atypia was insufficient in isolation to diagnose HCC. Additional studies, however, showed an increased Ki-67 proliferative rate (N = 10/10 stained cases). The Ki-67 proliferative rate was estimated to be between 5 and 10% in all tested cases and was clearly increased from adjacent liver at low power. Glypican 3 positivity (4 tumors) and alpha fetoprotein (AFP) (1/8 stained cases) positivity also helped make the diagnosis of HCC. Morphologically, the HCC had conventional morphology with five showing steatosis/steatohepatitic features and one showing intratumoral fibrosis. A control group of macroregenerative/dysplastic nodules showed no increase in Ki-67 proliferation and no staining for glypican 3. These findings highlight an important diagnostic pitfall: rare HCC show no reticulin loss on biopsy. In these challenging cases, additional findings are useful to make a diagnosis of HCC: increased Ki-67 and positive staining for aberrant expression of proteins such as glypican 3 or AFP.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AFP; Beta-catenin; Glypican 3; Hepatocellular carcinoma; Ki-67; Reticulin

Mesh:

Substances:

Year:  2020        PMID: 33039370      PMCID: PMC9177079          DOI: 10.1016/j.humpath.2020.09.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.526


  10 in total

1.  Scirrhous changes in dysplastic nodules do not indicate high-grade status.

Authors:  Hee J An; Peter Illei; Thomas Diflo; Devon John; Glyn Morgan; Lewis Teperman; Neil Theise
Journal:  J Gastroenterol Hepatol       Date:  2003-06       Impact factor: 4.029

2.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Authors:  Luca Di Tommaso; Annarita Destro; Jae Yeon Seok; Emanuela Balladore; Luigi Terracciano; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Ja June Jang; Eunsil Yu; So Young Jin; Emanuela Morenghi; Young Nyun Park; Massimo Roncalli
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

3.  Primary carcinoma of the liver in Uganda.

Authors:  P P Anthony
Journal:  J Pathol       Date:  1972-01       Impact factor: 7.996

4.  Identification of key challenges in liver pathology: data from a multicenter study of extramural consults.

Authors:  Michael S Torbenson; Christina A Arnold; Rondell P Graham; Dhanpat Jain; Sanjay Kakar; Dora M Lam-Himlin; Bita V Naini; Tsung-Teh Wu; Matthew Yeh
Journal:  Hum Pathol       Date:  2019-03-08       Impact factor: 3.466

5.  Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.

Authors:  Taofic Mounajjed; Saba Yasir; Patrice A Aleff; Michael S Torbenson
Journal:  Mod Pathol       Date:  2015-07-24       Impact factor: 7.842

6.  International consensus on histologic diagnosis of early hepatocellular neoplasia.

Authors:  Ian R Wanless
Journal:  Hepatol Res       Date:  2007-09       Impact factor: 4.288

7.  The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.

Authors:  Matthew M Yeh; Anne M Larson; Jean S Campbell; Nelson Fausto; Stephen J Rulyak; Paul E Swanson
Journal:  Am J Surg Pathol       Date:  2007-05       Impact factor: 6.394

Review 8.  Pathology of liver disease: advances in the last 50 years.

Authors:  Michael Torbenson; Kay Washington
Journal:  Hum Pathol       Date:  2019-09-04       Impact factor: 3.466

Review 9.  Update on the pathology of liver neoplasms.

Authors:  Karen E Matsukuma; Matthew M Yeh
Journal:  Ann Diagn Pathol       Date:  2018-10-12       Impact factor: 2.090

10.  Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.

Authors:  Heng Hong; Bryan Patonay; James Finley
Journal:  Diagn Pathol       Date:  2011-02-22       Impact factor: 2.644

  10 in total
  1 in total

1.  Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.

Authors:  Saba Yasir; Zongming E Chen; Dhanpat Jain; Sanjay Kakar; Tsung-Teh Wu; Matthew M Yeh; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2022-04-06       Impact factor: 6.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.